Treatment of Cervical Intraepithelial Neoplasia: Patients Preferences for Surgery or Immunotherapy with Imiquimod

Margot M. Koeneman*, Brigitte A. Essers, Cornelis G. Gerestein, Anna J. M. van de Sande, Rogier J. N. T. M. Litjens, Dieuwke Boskamp, Medi F. J. Goossens, Heleen J. Beekhuizen, Roy F. P. M. Kruitwagen, Arnold J. Kruse, Carmen D. Dirksen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)148-153
Number of pages6
JournalJournal of Immunotherapy
Volume40
Issue number4
DOIs
Publication statusPublished - May 2017

Keywords

  • cervical intraepithelial neoplasia
  • treatment
  • imiquimod
  • patient preferences
  • RANDOMIZED-CONTROLLED-TRIAL
  • METAANALYSIS
  • OUTCOMES

Cite this

Koeneman, M. M., Essers, B. A., Gerestein, C. G., van de Sande, A. J. M., Litjens, R. J. N. T. M., Boskamp, D., Goossens, M. F. J., Beekhuizen, H. J., Kruitwagen, R. F. P. M., Kruse, A. J., & Dirksen, C. D. (2017). Treatment of Cervical Intraepithelial Neoplasia: Patients Preferences for Surgery or Immunotherapy with Imiquimod. Journal of Immunotherapy, 40(4), 148-153. https://doi.org/10.1097/CJI.0000000000000158